tiprankstipranks
Trending News
More News >
Bio-Rad Laboratories (BIO)
NYSE:BIO
US Market
Advertisement

Bio-Rad Laboratories (BIO) Ratios

Compare
907 Followers

Bio-Rad Laboratories Ratios

BIO's free cash flow for Q2 2025 was $0.53. For the 2025 fiscal year, BIO's free cash flow was decreased by $ and operating cash flow was $0.65. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
5.12 5.83 5.55 2.92 3.39
Quick Ratio
3.67 4.34 4.29 2.08 2.40
Cash Ratio
0.67 0.77 0.76 0.69 1.05
Solvency Ratio
0.16 -0.14 -0.89 1.08 1.29
Operating Cash Flow Ratio
0.97 0.72 0.34 0.96 0.91
Short-Term Operating Cash Flow Coverage
410.89 771.49 418.17 1.34K 442.56
Net Current Asset Value
$ -274.30M$ -509.61M$ -728.44M$ -2.12B$ -952.84M
Leverage Ratios
Debt-to-Assets Ratio
0.14 0.11 0.09 <0.01 <0.01
Debt-to-Equity Ratio
0.20 0.16 0.12 <0.01 <0.01
Debt-to-Capital Ratio
0.16 0.14 0.11 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.14 0.12 0.11 <0.01 <0.01
Financial Leverage Ratio
1.43 1.41 1.40 1.30 1.31
Debt Service Coverage Ratio
11.05 -7.92 -88.45 2.17K 172.85
Interest Coverage Ratio
4.62 6.83 12.66 315.56 18.80
Debt to Market Cap
0.15 0.13 0.10 <0.01 <0.01
Interest Debt Per Share
53.46 49.81 41.51 0.42 1.21
Net Debt to EBITDA
1.51 -1.65 -0.17 -0.08 -0.13
Profitability Margins
Gross Profit Margin
52.82%53.42%55.93%56.14%56.48%
EBIT Margin
19.54%-29.97%-166.51%186.50%193.65%
EBITDA Margin
26.87%-22.77%-160.19%192.55%200.53%
Operating Profit Margin
8.85%12.65%17.22%16.75%16.14%
Pretax Profit Margin
17.62%-31.82%-167.87%186.08%192.79%
Net Profit Margin
12.50%-23.86%-129.45%145.57%149.83%
Continuous Operations Profit Margin
12.50%-23.86%-129.45%145.57%149.52%
Net Income Per EBT
70.91%74.97%77.11%78.23%77.72%
EBT Per EBIT
199.17%-251.66%-974.74%1111.12%1194.20%
Return on Assets (ROA)
3.12%-5.18%-26.87%23.93%29.40%
Return on Equity (ROE)
4.58%-7.29%-37.73%31.13%38.61%
Return on Capital Employed (ROCE)
2.34%2.87%3.73%2.86%3.33%
Return on Invested Capital (ROIC)
1.65%2.14%2.87%2.23%2.57%
Return on Tangible Assets
3.46%-5.51%-28.42%24.77%30.56%
Earnings Yield
4.08%-6.76%-28.96%18.87%21.98%
Efficiency Ratios
Receivables Turnover
5.44 5.46 5.67 6.90 6.07
Payables Turnover
8.65 8.60 9.14 9.03 7.94
Inventory Turnover
1.51 1.59 1.72 2.24 1.78
Fixed Asset Turnover
3.45 3.69 4.12 4.20 3.67
Asset Turnover
0.25 0.22 0.21 0.16 0.20
Working Capital Turnover Ratio
1.07 1.04 1.44 2.08 1.83
Cash Conversion Cycle
266.92 253.35 237.12 175.42 219.21
Days of Sales Outstanding
67.15 66.82 64.43 52.90 60.14
Days of Inventory Outstanding
241.96 228.95 212.61 162.94 205.02
Days of Payables Outstanding
42.19 42.42 39.91 40.42 45.95
Operating Cycle
309.11 295.77 277.03 215.83 265.16
Cash Flow Ratios
Operating Cash Flow Per Share
19.62 12.84 6.53 22.01 19.33
Free Cash Flow Per Share
12.76 7.47 2.70 17.96 16.00
CapEx Per Share
6.86 5.36 3.83 4.05 3.32
Free Cash Flow to Operating Cash Flow
0.65 0.58 0.41 0.82 0.83
Dividend Paid and CapEx Coverage Ratio
2.27 2.39 1.70 5.43 5.82
Capital Expenditure Coverage Ratio
2.86 2.39 1.70 5.43 5.82
Operating Cash Flow Coverage Ratio
0.38 0.27 0.16 59.67 40.93
Operating Cash Flow to Sales Ratio
0.21 0.14 0.07 0.22 0.23
Free Cash Flow Yield
4.47%2.31%0.64%2.38%2.75%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
24.50 -14.80 -3.45 5.30 4.55
Price-to-Sales (P/S) Ratio
3.04 3.53 4.47 7.71 6.82
Price-to-Book (P/B) Ratio
1.10 1.08 1.30 1.65 1.76
Price-to-Free Cash Flow (P/FCF) Ratio
22.35 43.21 155.99 42.07 36.42
Price-to-Operating Cash Flow Ratio
14.64 25.15 64.41 34.33 30.16
Price-to-Earnings Growth (PEG) Ratio
0.21 0.18 0.02 0.46 0.04
Price-to-Fair Value
1.10 1.08 1.30 1.65 1.76
Enterprise Value Multiple
12.83 -17.15 -2.96 3.92 3.27
Enterprise Value
8.80B 10.43B 13.29B 22.08B 16.70B
EV to EBITDA
12.83 -17.15 -2.96 3.92 3.27
EV to Sales
3.45 3.91 4.74 7.55 6.56
EV to Free Cash Flow
25.33 47.80 165.50 41.22 35.06
EV to Operating Cash Flow
16.48 27.83 68.34 33.63 29.04
Tangible Book Value Per Share
225.89 274.13 298.02 438.00 315.39
Shareholders’ Equity Per Share
261.83 299.26 322.82 458.15 331.90
Tax and Other Ratios
Effective Tax Rate
0.29 0.25 0.23 0.22 0.22
Revenue Per Share
93.81 91.45 94.08 97.97 85.52
Net Income Per Share
11.72 -21.82 -121.79 142.61 128.13
Tax Burden
0.71 0.75 0.77 0.78 0.78
Interest Burden
0.90 1.06 1.01 1.00 1.00
Research & Development to Revenue
0.12 0.09 0.09 0.09 0.09
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.01 0.02 0.02 0.02 0.02
Income Quality
-4.50 -0.59 -0.05 0.15 0.15
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis